Answers are grounded in this paper and cite their sources.
Introduction: Direct infection and viral protein expression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the respiratory system and other organs contribute to acute tissue dysfunction and post-COVID-19 syndrome. Mutations in SARS-CoV-2 genes can enhance or reduce its pathogenicity by affecting its transmissibility, disease severity, and overall mortality in human populations. Clinical reports indicate that one of the mutations in the open reading frame 3a (ORF3a) gene of SARS-CoV-2 (ORF3a-Q57H) is associated with increased transmission but lower patient mortality. However, it is still unknown how this mutation affects the function of the ORF3a protein and changes the severity of host cell damage. Hypothesis: The SARS-CoV-2-ORF3a-Q57H variant exhibits weaker activation of apoptotic signaling compared to original Wuhan-type (WT) ORF3a, which may contribute to the lower mortality. Methods: HEK293T cells and H9c2 cardiac myoblasts were transiently transfected with WT-ORF3a, mutant ORF3a-Q57H, or their control vector and used for biochemical and cell biological assays. Results: SARS-CoV-2-ORF3a-Q57H transfection produced ORF3a protein expression at levels similar to that of WT transfection, but showed significantly lower expression at the plasma membrane, as assessed by a cell-surface biotinylation. Caspase-8, which is mainly regulated by extrinsic pathways, was significantly activated by WT, but not by Q57H ORF3a. On the other hand, WT- and Q57H-transfected cells showed similar caspase-9 activity, which is mainly activated via intrinsic pathways. Caspase-3 activity, which is downstream of both intrinsic and extrinsic apoptotic pathways, was significantly higher in cells with WT compared to those with Q57H ORF3a. Lastly, the cell-surface biotinylation assay showed that WT-ORF3a (but not Q57H) transfection led to an increased expression of Fas-associated death domain (FADD) protein, a key adaptor protein that bridges death receptors and caspase-8 to trigger the extrinsic apoptotic pathway. Conclusion: SARS-CoV-2-ORF3a-Q57H variant expression induces less apoptosis in mammalian cells due to lower activation of the extrinsic apoptotic pathway, possibly via its decreased expression at the plasma membrane, where the death receptors and their signaling complexes are located. The relatively mild clinical phenotype observed in the Q57H variant may result from alterations in ORF3a functions caused by this mutation, particularly at the plasma membrane. Grants: This work is partially supported by the APS 2024 Summer Undergraduate Research Fellowship (to B.R.), OACA COVID-19 Response Grants (to J.O.-U. and B.S.J.), and IEM COVID-19 Response Grant (to J.O.-U.) from University of Minnesota. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
Rhee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: